Next Article in Journal
Genetic Correction of Stem Cells in the Treatment of Inherited Diseases and Focus on Xeroderma Pigmentosum
Next Article in Special Issue
An Emerging Role for Long Non-Coding RNA Dysregulation in Neurological Disorders
Previous Article in Journal
N,N’-alkylated Imidazolium-Derivatives Act as Quorum-Sensing Inhibitors Targeting the Pectobacterium atrosepticum-Induced Symptoms on Potato Tubers
Previous Article in Special Issue
Non-Coding RNAs in Muscle Dystrophies
Open AccessReview

Non-Coding RNAs: The “Dark Matter” of Cardiovascular Pathophysiology

Division of Cardiology, Magna Graecia University, URT Consiglio Nazionale delle Ricerche (CNR), Catanzaro 88100, Italy
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2013, 14(10), 19987-20018;
Received: 4 July 2013 / Revised: 12 September 2013 / Accepted: 16 September 2013 / Published: 9 October 2013
(This article belongs to the Special Issue Regulation by non-coding RNAs 2013)
Large-scale analyses of mammalian transcriptomes have identified a significant number of different RNA molecules that are not translated into protein. In fact, the use of new sequencing technologies has identified that most of the genome is transcribed, producing a heterogeneous population of RNAs which do not encode for proteins (ncRNAs). Emerging data suggest that these transcripts influence the development of cardiovascular disease. The best characterized non-coding RNA family is represented by short highly conserved RNA molecules, termed microRNAs (miRNAs), which mediate a process of mRNA silencing through transcript degradation or translational repression. These microRNAs (miRNAs) are expressed in cardiovascular tissues and play key roles in many cardiovascular pathologies, such as coronary artery disease (CAD) and heart failure (HF). Potential links between other ncRNAs, like long non-coding RNA, and cardiovascular disease are intriguing but the functions of these transcripts are largely unknown. Thus, the functional characterization of ncRNAs is essential to improve the overall understanding of cellular processes involved in cardiovascular diseases in order to define new therapeutic strategies. This review outlines the current knowledge of the different ncRNA classes and summarizes their role in cardiovascular development and disease. View Full-Text
Keywords: non-coding RNA; microRNA; long non-coding RNA; vascular development; vascular disease; heart pathophysiology non-coding RNA; microRNA; long non-coding RNA; vascular development; vascular disease; heart pathophysiology
Show Figures

Graphical abstract

MDPI and ACS Style

Iaconetti, C.; Gareri, C.; Polimeni, A.; Indolfi, C. Non-Coding RNAs: The “Dark Matter” of Cardiovascular Pathophysiology. Int. J. Mol. Sci. 2013, 14, 19987-20018.

AMA Style

Iaconetti C, Gareri C, Polimeni A, Indolfi C. Non-Coding RNAs: The “Dark Matter” of Cardiovascular Pathophysiology. International Journal of Molecular Sciences. 2013; 14(10):19987-20018.

Chicago/Turabian Style

Iaconetti, Claudio; Gareri, Clarice; Polimeni, Alberto; Indolfi, Ciro. 2013. "Non-Coding RNAs: The “Dark Matter” of Cardiovascular Pathophysiology" Int. J. Mol. Sci. 14, no. 10: 19987-20018.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop